FULL POSTER SESSION ABSTRACTSBiochemistry and Metabolism1. Heme regulation in Aspergillus fumigatus. Nicola Beckmann 1 , Ernst R. Werner 2 , Hubertus Haas 1 . 1) Division of Molecular Biology, Biocenter, InnsbruckMedical University, Austria; 2) Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Austria.Sufficient iron supply is indispensable for survival of almost all organisms. However, an excess of iron is potentially toxic. In the opportunistic humanpathogenicfungus Aspergillus fumigatus the ability to adapt to iron limitation represents a crucial virulence factor. Iron regulation is tightly interconnectedwith heme metabolism, as iron-containing heme is an essential cofactor of a variety of cellular processes, e.g. respiration, sterol biosynthesis, oxidativestress detoxification and also reductive iron assimilation. Most knowledge on fungal heme regulation derives from studies in Saccharomyces cerevisiae. A.fumigatus, as well as most other fungal species, lack homologs of key heme regulators found in S. cerevisiae. The goal of this study is to elucidate hemedependentregulation in A. fumigatus (wt). As a first step, we generated a mutant strain (DhemA) lacking the gene encoding aminolevulinic acid synthase(HemA), which catalyzes the committed step in heme biosynthesis. This mutation offers the possibility to control the cellular heme content bysupplementation with aminolevulinic acid (ALA). Growth of DhemA was blocked at ALA concentrations below 20 mM, but fully restored by addition of 200mM on solid as well as in liquid media. Supplementation with protoporphyrin IX (PpIX), the iron free heme precursor, and hemin (chloroprotoporphyrin IXiron(III)) supported growth of DhemA, proving that A. fumigatus is able to utilize exogenous porphyrins. Nevertheless, A. fumigatus in contrast to severalother fungal species is not able to utilize hemin as iron source. Under iron starvation, ALA supplementation led to a tremendous accumulation of PpIX inboth DhemA and wt, which indicates that HemA represents the major rate limiting step in heme biosynthesis when iron is scarce. In DhemA, ALArestriction transcriptionally increased the heme-biosynthetic coproporphyrinogen(III)oxidase and the putative heme receptor CFEM3. Additionally, ALAlimitation decreased the resistance of DhemA to oxidative stress and the triazole antifungal drug posaconazole, which underlines the crucial role of hemein detoxification and sterol biosynthesis. This work was supported by the Austrian Science Foundation grant FWF P21643-B11 to HH.2. Key Steps in the Biosynthesis of the <strong>Fungal</strong> Virulence Factor Gliotoxin. Pranatchareeya Chankhamjon 1 , Daniel H. Scharf 2 , Kirstin Scherlach 1 , NicoleRemme 1 , Andreas Habel 1 , Thorsten Heinek 2 , Martin Roth 3 , Axel A. Brakhage 2 , Christian Hertweck 1 . 1) Biomolecular Chemistry, HKI, Jena, Jena, Germany; 2)Molecular and Applied Microbiology,HKI, Jena, Jena, Germany; 3) Bio Pilot Plant,HKI, Jena, Jena, Germany.The prototype of epipolythiodioxopiperazine (ETP) family, gliotoxin, is an infamous virulence factor of the human pathogen Aspergillus fumigatus,notably the leading cause of invasive aspergillosis in the immunocompromised patients. Its toxicity has been attributed to the unusual intramoleculardisulfide bridge, which is the functional motif of all ETPs. A number of studies showed that the diketopiperazine core of gliotoxin is assembled by a nonribosomalpeptide synthetase. However, downstream pathway steps have remained elusive, mainly because of the scarcity and instability of pathway inthe mediates produced. Here we present the critical role of a specialized glutathione S-transferase (GST), GliG, in the enzymatic sulfurisation and the keystep of epidithiol formation by an unprecedented twin carbon-sulfur lyase, GliI. Our studies not only unveil the understanding of key steps in thebiosynthesis pathway of an important virulence factor, but also outline a new function of microbial GSTs and gain insights into the formation oforganosulfur compounds.3. Identification of a gene cluster mediating the biosynthesis of the Aspergillus fumigatus cell wall and secreted polysaccharide, galactosaminogalactan.Fabrice N. Gravelat 1 , Mark J. Lee 1 , Alexander Geller 1 , Dan Chen 2 , Anne Beauvais 3 , Hong Liu 4 , William C. Nierman 2 , Jean-Paul Latge 3 , Thierry Fontaine 3 , ScottG. Filler 4 , Donald C. Sheppard 1 . 1) Microbiology & Immunology Department, McGill University, Montréal, Qc, Canada; 2) J. Craig Venter Institute, Rockville,Maryland, USA; 3) Aspergillus Unit, Institut Pasteur, Paris, France; 4) Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.Aspergillus fumigatus is the most common cause of invasive mold disease in humans. Although adherence of fungal hyphae to host constituents is acritical early step in the pathogenesis of invasive aspergillosis, the molecular mechanisms underlying this process have not been elucidated. Using aforward genetic approach, we identified a glucose epimerase, Uge3, which is required for adherence of hyphae to a wide variety of substrates.Biochemical analyses confirmed that Uge3 is required for the synthesis of the secreted glycan galactosaminogalactan (GAG), which in turn functions as thedominant adhesin of A. fumigatus hyphae and is required for virulence. However, the biochemical and regulatory pathways governing GAG synthesisremain unknown. Using comparative transcriptome analysis, we found that uge3 is found within a cluster of 5 co-regulated genes on chromosome 3.Interestingly, 3 of the 5 proteins (Uge3, Gtb3 and Ega3) encoded by these genes are predicted to contain conserved domains involved in polysaccharidemetabolism. The 2 other proteins (Sph3 and Esr3) have no homologs in other organisms. We hypothesized that this cluster of genes may be required forGAG biosynthesis. To test this hypothesis, we constructed deletion mutants of two of the cluster genes: sph3, encoding a cell surface spherulin 4-likeprotein; and esr3, encoding an extracellular serin-rich protein. Phenotypic analysis of both the Desr3 and Dsph3 mutant strains confirmed that deletion ofthese genes resulted in both impaired GAG production and impaired adherence, similar to the phenotype of the Duge3 mutant strain. Gene deletion forthe 2 remaining genes is ongoing. Collectively, these data suggest that the 5 gene cluster identified on chromosome three is likely a carbohydratebiosynthetic cluster required for the synthesis of GAG. Importantly, this is the first description of a gene cluster for the biosynthesis of a cell wallpolysaccharide in A. fumigatus, and suggests the possibility that other similar gene clusters may govern the synthesis of glycans in this fungus. Thediscovery of this cluster, and the subsequent characterization of the role of each of the component elements, may provide insight into the synthesis andfunction of GAG.4. A fasciclin-like protein in Aspergillus fumigatus. Thomas Hartmann 1 , Lei Sun 2 , Cheng Jin 1 . 1) Institute of Microbiology, Chinese Academy of Sciences,Beijing, China; 2) Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.The saprophytic filamentous fungus Aspergillus fumigatus has been gaining importance as an opportunistic human pathogen over the past decades, asadvances in modern medicine have created a growing group of patients susceptible to potentially deadly invasive aspergillosis. The role of fungal adhesionduring infection progression is still poorly understood and this work aims to focus on this neglected aspect of the infection process. Fasciclin-like proteinscan be found in a wide variety of organisms, where they often perform functions related to surface adhesion. Here we describe a fasciclin-like protein in A.fumigatus. The Fas protein was first discovered as differentially expressed in an O-mannosyltransferase Dpmt1 deletion strain, which indicates that it maybe substantially glycosylated. We generated Dfas deletion strains in two different A. fumigatus strain backgrounds. The Dfas deletion strains grewnormally on plates and in solution and neither bright field microscopy, nor TEM revealed phenotypical differences to the wildtype strains. Interestingly, theDfas deletion strains showed reduced adhesion to hydrophobic plastic surfaces, but adhered normally to glass slides. Whether these altered adhesiveproperties have an effect on the strains’ virulence in mammalian hosts such as mice remains to be investigated.122
FULL POSTER SESSION ABSTRACTS5. Characterization of fumiquinazoline biosynthesis in Aspergillus fumigatus. Fang Yun Lim 1 , Brian Ames 2 , Christopher Walsh 2 , Nancy Keller 1 . 1) Medicalmicrobiology and Immunology, University of Wisconsin-Madison, Madison, WI; 2) Biological chemistry and molecular pharmacology, Harvard MedicalSchool, Boston, MA.The fumiquinazolines (FQs) comprise a related, sequentially generated family of bioactive peptidyl alkaloids that are signature metabolites of Aspergillusfumigatus. The FQ framework is built by nonribosomal peptide synthetase (NRPS) machinery with anthranilate as a key non-proteinogenic amino acidbuilding block. Despite being prevalent across the species, its gene cluster has not been characterized. Prior bioinformatic analysis coupled withheterologous expression of the putative A. fumigatus proteins termed here FmqA -FmqD led to the identification of a four-enzymatic process that buildsincreasingly complex FQ scaffolds. Briefly, FmqA, a trimodular NRPS condenses alanine, tryptophan, and anthranilic acid to form fumiquinazoline F (FQF).The tandem action of a flavoprotein (FmqB) and a monomodular NRPS (FmqC) converts FQF to fumiquinazoline A (FQA). Finally, FmqD, a FAD-dependentoxidoreductase converts FQA to the heptacyclic fumiquinazoline C (FQC). Interestingly, FmqD contains an N-terminus signal peptide predicted forextracellular transport. This study is aimed at providing in vivo validation to the FQ biosynthetic framework and characterizing how cellular localization ofFmqD affects production of FQC in A. fumigatus. We found that the conidial metabolite, FQC, is the predominant FQ moiety in two wild type isolates and isselectively accumulated in the conidia. Targeted single gene deletions of FmqA through FmqD coupled with metabolomic profiling of the singlebiosynthetic gene mutants supported previous biochemical prediction of FQ biosynthesis. Fluorescent microscopy of mutants bearing a C-terminal FmqD-GFP fusion showed that FmqD is localized to the cell wall of the fungus and this localization is abolished when the signal peptide is removed. Future studieswill elucidate if cell wall localization of FmqD is crucial for FQC production.6. Identification of local and cross-chromosomal biosynthetic gene clusters in filamentous fungi using gene expression data. Mikael R. Andersen 1 , JakobB. Nielsen 1 , Andreas Klitgaard 1 , Lene M. Petersen 1 , Tilde J. Hansen 1 , Lene H. Blicher 1 , Charlotte H. Gottfredsen 2 , Thomas O. Larsen 1 , Kristian F. Nielsen 1 ,Uffe H. Mortensen 1 . 1) Department of Systems Biology, Technical University of Denmark, Kgs Lyngby, Denmark; 2) Department of Chemistry, TechnicalUniversity of Denmark, Kgs Lyngby, Denmark.Biosynthetic pathways of secondary metabolites from fungi are currently subject to an intense effort to elucidate the genetic basis for these compoundsdue to their large potential within pharmaceutics and synthetic biochemistry. The preferred method is methodological gene deletions to identifysupporting enzymes for key synthases one cluster at a time.In earlier work we presented a method for using a gene expression compendium to accurately predict co-regulated gene clusters in general, and inparticular the members of gene clusters for secondary metabolism. A benchmarking of the method in Aspergillus nidulans by comparison to previous genedeletion studies showed the method to be accurate in 13 out of 16 known clusters and nearly accurate for the remaining three.In this work, we have expanded the algorithm to identify cross-chemistry between physically separate gene clusters (super clusters), and validate thisboth with legacy data and experimentally by prediction and verification of a new supercluster consisting of the non-ribosomal peptide synthetase (NRPS)AN1242 (on chr VIII) and the prenyltransferase AN11080 (on chromosome V) as well as identication of the shared product compound nidulanin A.We also propose further implications of the gene clustering, as our analysis shows that approximately 10 % of the genes seem to be non-randomly(p
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76: CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78: CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80: CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82: CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84: CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86: CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88: CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90: CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92: CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94: CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96: CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98: CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100: CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102: CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104: CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106: CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108: LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110: LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112: LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114: LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116: LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118: LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120: LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122: LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124: LISTING OF ALL POSTER ABSTRACTS640.
- Page 125: LISTING OF ALL POSTER ABSTRACTS723.
- Page 129 and 130: FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132: FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134: FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136: FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138: FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140: FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142: FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144: FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146: FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148: FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150: FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152: FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154: FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156: FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158: FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160: FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162: FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164: FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166: FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168: FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170: FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172: FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174: FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176: FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178:
FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180:
FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182:
FULL POSTER SESSION ABSTRACTSmore g
- Page 183 and 184:
FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186:
FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188:
FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190:
FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192:
FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194:
FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196:
FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198:
FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200:
FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202:
FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204:
FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206:
FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208:
FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210:
FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212:
FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214:
FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216:
FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218:
FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220:
FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222:
FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224:
FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226:
FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228:
FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230:
FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232:
FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234:
FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236:
FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238:
FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240:
FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242:
FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244:
FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246:
FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248:
FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250:
FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252:
FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254:
FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256:
FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258:
FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260:
FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262:
FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264:
FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266:
FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268:
FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270:
FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272:
FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274:
FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276:
FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278:
FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280:
FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282:
FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284:
FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286:
FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288:
FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290:
FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292:
FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294:
FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296:
FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298:
FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300:
FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302:
FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304:
FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306:
FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308:
KEYWORD LISTABC proteins ..........
- Page 309 and 310:
KEYWORD LISThigh temperature growth
- Page 311 and 312:
AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314:
AUTHOR LISTFrancis, Martin ........
- Page 315 and 316:
AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318:
AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320:
AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322:
AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324:
LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326:
LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328:
LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni